Energy News / Shareholders Foundation, Inc.

NASDAQ:ONCE Investor Alert: Lawsuit Filed Against the Acquisition of Spark Therapeutics, Inc.

Via: ReleaseWire

Updated 12:00 PM CDT, Mon, March 18,2019

A lawsuit was filed for investors in shares of Spark Therapeutics, Inc. (NASDAQ: ONCE) in connection with the proposed takeover and NASDAQ: ONCE stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 03/18/2019 -- An investor, who currently holds shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), filed a lawsuit against the takeover of Spark Therapeutics, Inc.

Investors who purchased shares of Spark Therapeutics, Inc. (NASDAQ: ONCE) and currently hold any of those Spark Therapeutics, Inc. (NASDAQ: ONCE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: ONCE stockholders by agreeing to sell Spark Therapeutics, Inc. cheaply via an unfair process.

Philadelphia, PA based Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. On February 25, 2019, Spark Therapeutics (NASDAQ: ONCE) announced that it has entered into a merger agreement for Roche to fully acquire Spark Therapeutics at a price of $114.50 per share in an all-cash transaction.

However, plaintiff claims that the proposed consideration NASDAQ: ONCE shareholders will receive is grossly inadequate and undervalues Spark Therapeutics, Inc. Indeed, at least one analyst has set the high target price NASDAQ: ONCE shares at $115.00 per share. In addition, the plaintiff alleges that the process is also unfair NASDAQ: ONCE stockholders.

Shares of Spark Therapeutics, Inc. (NASDAQ: ONCE) closed on March 15, 2019, at $113.59 per share.

Those who are current investors in Spark Therapeutics, Inc. (NASDAQ: ONCE) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqonce-investor-alert-lawsuit-filed-against-the-acquisition-of-spark-therapeutics-inc-1173913.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com